According to current research, over 25% of lung adenocarcinoma mutations are RAS mutations (49), and the Kristin isoform of Ras (K-Ras) is mutated in over 90% of pancreatic ductal adenocarcinomas (50). This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.